blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0270799

EP0270799 - Pharmaceutical compositions of recombinant beta-interferon and formulation processes [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  22.07.1995
Database last updated on 03.06.2024
Most recent event   Tooltip28.11.2003Lapse of the patent in a contracting state
New state(s): ES
published on 14.01.2004  [2004/03]
Applicant(s)For all designated states
CETUS ONCOLOGY CORPORATION
1400 Fifty-Third Street Emeryville
California 94608 / US
[N/P]
Former [1992/36]For all designated states
CETUS ONCOLOGY CORPORATION
1400 Fifty-Third Street
Emeryville California 94608 / US
Former [1988/24]For all designated states
CETUS CORPORATION
1400 Fifty-Third Street
Emeryville California 94608 / US
Inventor(s)01 / Shaked, Ze'ev
1038 Sierra Street
Berkeley, CA 94707 / US
02 / Stewart, Tracy
2376 Bryant Street
San Francisco, CA 94110 / US
03 / Thomson, Jody
811 Talbot Avenue
Albany, CA 94706 / US
04 / Thomson, James William
811 Talbot Avenue
Albany, CA 94706 / US
05 / Taforo, Terrance
379A, Somerset Road
Oakland, CA 94611 / US
06 / Hershenson, Susan
1275 Eighth Avenue, No. 103
San Francisco, CA 94122 / US
[1994/38]
Former [1988/24]01 / Shaked, Ze'ev
1038 Sierra Street
Berkeley California 94707 / US
02 / Stewart, Tracy
2376 Bryant Street
San Francisco California 94110 / US
03 / Thomson, Jody
811 Talbot Avenue
Albany California 94706 / US
04 / Thomson, James William
811 Talbot Avenue
Albany California 94706 / US
05 / Taforo, Terrance
379A, Somerset Road
Oakland California 94611 / US
06 / Hershenson, Susan
1275 Eighth Avenue, No. 103
San Francisco California 94122 / US
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [1988/24]VOSSIUS & PARTNER
Postfach 86 07 67
D-81634 München / DE
Application number, filing date87115693.126.10.1987
[1988/24]
Priority number, dateUS1986092342327.10.1986         Original published format: US 923423
[1988/24]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0270799
Date:15.06.1988
Language:EN
[1988/24]
Type: B1 Patent specification 
No.:EP0270799
Date:21.09.1994
Language:EN
[1994/38]
Search report(s)(Supplementary) European search report - dispatched on:EP19.04.1988
ClassificationIPC:A61K37/66, A61K47/08, A61K47/10, A61K47/14
[1994/38]
CPC:
A61K38/215 (EP); A61K47/10 (EP); A61K47/14 (EP);
A61K47/26 (EP); A61K9/0019 (EP)
Former IPC [1988/24]A61K45/02, A61K47/00
Designated contracting statesAT,   BE,   CH,   DE,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1988/24]
TitleGerman:Pharmazeutische Zusammensetzungen von rekombinantem beta-Interferon und Herstellungsverfahren[1994/38]
English:Pharmaceutical compositions of recombinant beta-interferon and formulation processes[1988/24]
French:Compositions pharmaceutiques de bêta-interféron recombinant et procédés de préparation[1988/24]
Former [1988/24]Pharmazeutische Zusammensetzungen von rekombinanten beta-Interferon und Herstellungsverfahren
Biological materialThis application mentions deposited biological material, check the file for details
Examination procedure24.10.1988Examination requested  [1988/51]
16.03.1990Despatch of a communication from the examining division (Time limit: M07)
26.10.1990Reply to a communication from the examining division
22.01.1991Despatch of a communication from the examining division (Time limit: M02)
15.03.1991Reply to a communication from the examining division
24.06.1991Despatch of a communication from the examining division (Time limit: M04)
04.11.1991Reply to a communication from the examining division
16.03.1992Despatch of a communication from the examining division (Time limit: M02)
26.05.1992Reply to a communication from the examining division
01.10.1992Despatch of a communication from the examining division (Time limit: M02)
11.12.1992Reply to a communication from the examining division
04.06.1993Despatch of communication of intention to grant (Approval: No)
10.11.1993Despatch of communication of intention to grant (Approval: later approval)
19.11.1993Communication of intention to grant the patent
28.02.1994Fee for grant paid
28.02.1994Fee for publishing/printing paid
Opposition(s)22.06.1995No opposition filed within time limit [1995/37]
Fees paidRenewal fee
03.10.1989Renewal fee patent year 03
20.09.1990Renewal fee patent year 04
30.10.1991Renewal fee patent year 05
18.09.1992Renewal fee patent year 06
27.10.1993Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipGR21.09.1994
ES01.01.1995
[2004/03]
Former [2000/04]GR21.09.1994
Documents cited:Search[XP]JP61277633  ;
 [Y]JP80102519  ;
 [Y]EP0107498  (GENENTECH INC [US]);
 [Y]EP0150067  (TAKEDA CHEMICAL INDUSTRIES LTD [JP]);
 [Y]EP0152345  (INTERFERON SCIENCES INC [US]);
 [X]US4606917  (EPPSTEIN DEBORAH A [US]);
 [APD]EP0215658  (CETUS CORP [US])
 [XP]  - CHEMICAL ABSTRACTS, vol. 106, 6th April 1987, page 373, abstract no. 107907k, Columbus, Ohio, US; & JP-A-61 277 633 (TORAY INDUSTRIES, INC.) 08-12-1986, & JP61277633 A 00000000
 [Y]  - CHEMICAL ABSTRACTS, vol. 94, 1981, page 312, abstract no. 20423j, Columbus, Ohio, US; & JP-A-80 102 519 (GREEN CROSS CORP.) 05-08-1980, & JP80102519 A 00000000
Examination   - CHEMICAL ABSTRACTS, vol. 106, 06 April 1987, Columbus, OH (US); p. 373, no. 107907k#
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.